France, May 22 -- With the announcement of 852 projects funded by foreign direct investment in 2025, France remains ahead of the United Kingdom and Germany in the 2026 European Attractiveness Survey b... Read More
Nigeria, May 22 -- The Nigeria Police Force (NPF) has condemned the conduct of Newton Isokpehi, an assistant superintendent of police (ASP), who recorded himself in a video, threatening to kill anyone... Read More
नई दिल्ली, मई 22 -- हिंदू धर्म में एकादशी तिथि भगवान विष्णु की पूजा के लिए बेहद खास मानी जाती है। लेकिन ज्येष्ठ महीने में पड़ने वाली निर्जला एकादशी का महत्व सबसे अलग बताया गया है। मान्यता है कि इस व्र... Read More
Singapore, May 22 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembro... Read More
Singapore, May 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evalu... Read More
Singapore, May 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More
Singapore, May 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More
Singapore, May 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending D... Read More
Singapore, May 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending D... Read More
Singapore, May 22 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combine... Read More